Every 12 minutes1, a person with diabetes thinks about their condition. For many, this constant burden leads todiabetes distress—a state of emotional strain linked with anxiety, depression2, and often associated with uncontrolled blood sugar. In India, one in three people3with type 2 diabetes experience distress, with nearly 86%4reporting anxiety or depressive symptoms. Despite its impact, diabetes distress has often been confused with depression. Real-world care has often lacked clarity, structured approaches, and tools for clinicians to address the emotional side of diabetes. Recognizing this gap, the European Association for the Study of Diabetes (EASD) has issued the first-ever global guidelines on diabetes distress at its Annual Meeting 2025 in Vienna. Developed with patient inputand global standards, these guidelines aim to embed emotional support into routine diabetes care. Key Recommendations include: In conclusion, this first-ever guideline provides a vital framework to address diabetes distress, embedding emotional support into routine care and improving outcomes for people with diabetes. References:
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!